Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 18 | Intrator Michael NDirector, CEO and President, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $37K 394 sh |
| Jan 16, 2026 traded Jan 14, 2026 |
| 18 | Intrator Michael NDirector, CEO and President, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $7,358 79 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 18 | Schwartz Harold JDirector, 10% Owner | Disposition to issuer | D | $4.62M 888.4K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 18 | Stein CliffordDirector | Disposition to issuer | D | $1.46M 280.9K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 18 | Conrad Micah R.EVP & COO | Tax withholding | F | $1.07M 16.2K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 17 | Howze YalondaCHIEF LEGAL OFFICER | Option exercise | M | — 335 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 17 | Osterhout Jeannette EEVP & CFO | Grant or award | A | — 26.4K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 17 | Nithrakashyap ArvindDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $327K 4,648 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 17 | Bothwell Ian TDirector, CEO & CFO, 10% Owner | Grant or award | A | — 175.0K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 17 | Baumgartner FlorianEVP and CEO, Vista | Option exercise | M | — 1,026 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 17 | Mcdonough GeoffDirector | Option exercise | M | — 395 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 17 | Sedor ChristianChief Accounting Officer | Tax withholding | F | $9,713 879 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 17 | Conway Kevin JohnChief Financial Officer | Option exercise | M | — 59 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 17 | DiPerna DinoSVP Global R&D | Open-market sale · 10b5-1 plan | SELL | $622K 2,527 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 17 | Cree BrianPresident | Open-market sale · 10b5-1 plan | SELL | $321K 16.2K sh | Jan 16, 2026 traded Jan 15, 2026 |
| 17 | Ugwumba Chidozie10% Owner | Open-market sale | SELL | $100K 19.6K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 17 | Shapiro George CraigDirector, Chief Medical Officer | Grant or award | A | — 175.0K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 17 | Ugwumba Chidozie10% Owner | Open-market sale | SELL | $64K 12.6K sh | Jan 16, 2026 traded Jan 15, 2026 |
| 17 | Ho-Sing-Loy Paul AVP, Chief Information Officer | Grant or award | A | — 1,243 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 16 | Yeh Kuanling AmyChief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $34K 3,000 sh | Jan 16, 2026 traded Jan 16, 2026 |
| 16 | Gooden NathanDirector | Grant or award | A | $67K 6,667 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 16 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $280K 600 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 15 | Argen JohnDirector | Disposition to issuer | D | $297K 57.2K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 15 | Oseland Robert LChief Operating Officer | Option exercise | M | — 141.7K sh | Jan 16, 2026 traded Jan 13, 2026 |
| 15 | Hsieh Anthony LiDirector, Executive Chair, CEO & Pres., 10% Owner | Open-market sale · 10b5-1 plan | SELL | $1.10M 415.5K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 15 | O'Kelly CiaranDirector | Grant or award | A | — 1,168 sh | Jan 16, 2026 traded Jan 12, 2026 |
| 15 | Oseland Robert LChief Operating Officer | Option exercise | M | — 125.0K sh | Jan 16, 2026 traded Jan 13, 2026 |
| 14 | Nithrakashyap ArvindDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $73K 1,045 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 14 | Choudary Kiran KumarChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $968K 14.4K sh | Jan 16, 2026 traded Jan 16, 2026 |
| 14 | Wren ChrisVP of Operations | Open-market sale | SELL | $5,529 30.0K sh | Jan 16, 2026 traded Jan 16, 2026 |
| 14 | Choudary Kiran KumarChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $372K 5,427 sh | Jan 16, 2026 traded Jan 16, 2026 |
| 13 | Mercier MattCFO | Grant or award | A | — 6,896 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $108K 240 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | D'Amico AndrewDirector | Open-market sale · 10b5-1 plan | SELL | $30K 200 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $168K 360 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm | Option exercise · 10b5-1 plan | M | $513K 3,054 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Devaisher Len DPresident and COO | Grant or award | A | — 2,131 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $186K 400 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Sims Gary LSVP & Chief Credit Officer | Grant or award | A | — 1,066 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $145K 320 sh | Jan 16, 2026 traded Jan 15, 2026 |